CompletedNCT01786369
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In Glen OaksSchizophrenia, BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia, Bipolarity
WithdrawnNCT01981811
This study has public registry information in the United States. It is testing Medical Information Device #1 for schizophrenia.
Multiple locations, including CerritosBipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity, Schizophrenia
OngoingEUCTR 2014-003803-31
This study is ongoing. It focuses on bipolarity and currently lists study information in Spain.
In SpainBipolarityOther
- Countries
- Spain
- Sponsor
- Hospital Universitario Araba (Sede Santiago)
- Condition
- Bipolarity
Active Not RecruitingNCT05357313
This study is active but not recruiting. It focuses on bipolarity and currently lists study information in China.
In Hong KongBipolarity, DepressionBehavioralFrom 18 Years to 65 Years
- Countries
- China
- Sponsor
- Chinese University of Hong Kong
- Condition
- Bipolarity, Depression
TerminatedNCT01928043
This study has public registry information. It focuses on bipolarity and currently lists study information in Canada.
In TorontoBipolarityDrugFrom 13 Years to 19 Years
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
- Condition
- Bipolarity
TerminatedNCT01784666
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In BostonBipolarity, DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Bipolarity, Depression
TerminatedNCT01131559
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In MasonBipolarity, DepressionDrugFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Lindner Center of HOPE
- Condition
- Bipolarity, Depression
TerminatedNCT02402738
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In ProvidenceBipolarityBehavioralOver 18 Years
- Countries
- United States
- Sponsor
- Brown University
- Condition
- Bipolarity
CompletedNCT00572117
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Palo AltoBipolarityDrugOver 18 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- Bipolarity
TerminatedNCT02726659
This study has public registry information. It focuses on bipolarity and currently lists study information in Canada.
In LondonBipolarity, DepressionDrugFrom 18 Years to 45 Years
- Countries
- Canada
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Condition
- Bipolarity, Depression
CompletedNCT00483548
This study is completed. It focuses on bipolarity and currently lists study information in Australia, India, and the United States.
Multiple locations, including ChandlerBipolarity, DepressionDrugOver 18 Years
- Countries
- United States, Australia, India
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity, Depression
CompletedNCT02506322
This study is completed. It focuses on bipolarity and currently lists study information in Germany.
In TübingenBipolarityBehavioralFrom 18 Years to 55 Years
- Countries
- Germany
- Sponsor
- University Hospital Tuebingen
- Condition
- Bipolarity
